ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Acute myelomonocytic leukaemia | 01.10.05.005; 16.01.05.005 | 0.000139% | | Not Available |
Arterial rupture | 24.03.02.027; 12.01.11.010 | 0.000533% | | Not Available |
Bladder sphincter atony | 20.03.03.006; 17.05.01.023 | 0.001332% | | Not Available |
Blood pressure immeasurable | 13.14.03.026 | 0.001332% | | Not Available |
Bronchial fistula | 22.03.02.011 | 0.000799% | | |
Cardiac failure chronic | 02.05.01.009 | 0.000139% | | Not Available |
Cellulitis orbital | 06.04.11.001; 11.02.01.035 | 0.001865% | | Not Available |
Culture stool positive | 13.08.02.006 | 0.000799% | | Not Available |
Culture urine positive | 13.08.02.007 | 0.000533% | | Not Available |
Full blood count decreased | 13.01.07.004 | - | - | Not Available |
Lung adenocarcinoma | 22.08.01.007; 16.19.01.002 | 0.000278% | | Not Available |
Lymphadenopathy mediastinal | 22.09.03.006; 01.09.01.025 | 0.000533% | | Not Available |
Malignant pleural effusion | 22.05.04.001; 16.32.03.014 | 0.000139% | | Not Available |
Metastases to bone | 16.22.02.005; 15.09.03.006 | 0.002398% | | Not Available |
Metastases to lymph nodes | 16.22.02.006; 01.09.01.015 | 0.000208% | | Not Available |
Mixed deafness | 04.02.01.014; 17.04.07.006 | 0.000799% | | Not Available |
Pancreatic carcinoma metastatic | 16.13.10.003; 07.21.09.006 | 0.000208% | | Not Available |
Pulmonary artery thrombosis | 24.01.06.005; 22.06.02.005 | 0.000799% | | Not Available |
Recurrent cancer | 16.16.01.015 | 0.000533% | | Not Available |
Seminoma | 21.13.02.004; 16.25.03.002 | 0.000533% | | Not Available |
Systemic sclerosis | 23.03.02.021; 15.06.01.019; 10.04.07.006; 07.11.02.008; 24.03.03.041 | 0.000208% | | Not Available |
Pericardial effusion malignant | 16.32.03.026; 02.06.01.009 | 0.000533% | | Not Available |
Pneumocephalus | 17.02.05.060; 12.02.04.009 | 0.000533% | | Not Available |
Metastases to meninges | 17.02.10.012; 16.22.02.003 | 0.000208% | | Not Available |
Enterobacter infection | 11.02.09.002 | 0.001066% | | Not Available |
Brain natriuretic peptide increased | 13.02.04.011 | 0.001332% | | Not Available |
Laryngeal discomfort | 22.02.05.040 | 0.000533% | | Not Available |
Superior mesenteric artery syndrome | 24.03.03.040; 07.13.06.009 | 0.001332% | | Not Available |
Clostridium difficile infection | 11.02.02.009 | 0.001066% | | Not Available |
Thyroid cancer metastatic | 16.24.03.006; 05.02.05.009 | 0.000139% | | Not Available |